CYTOSORBENTS CORPORATION Comprehensive Income
CYTOSORBENTS CORPORATION (CTSO) reported Comprehensive Income of -$3.31 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- CYTOSORBENTS CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$3.31M.
- CYTOSORBENTS CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$4.25M.
- CYTOSORBENTS CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$4.63M.
- CYTOSORBENTS CORPORATION comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$3.05M.
- CYTOSORBENTS CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$15.43M.
- CYTOSORBENTS CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$17.00M.
- CYTOSORBENTS CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$31.05M.
- CYTOSORBENTS CORPORATION comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$31.01M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 191 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 194 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 197 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 200 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 203 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 206 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 209 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.31M 10-Q · filed 2026-08-06 | -$7.57M 10-Q · filed 2026-08-06 | -$12.20M derived: sum of 3 quarters · filed 2026-08-06 | -$15.25M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2026-03-31 | -$4.25M 10-Q · filed 2026-05-13 | -$8.88M derived: sum of 2 quarters · filed 2026-05-13 | -$11.94M derived: sum of 3 quarters · filed 2026-05-13 | -$15.47M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-12-31 | -$4.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$7.68M derived: sum of 2 quarters · filed 2026-03-30 | -$11.21M derived: sum of 3 quarters · filed 2026-08-06 | -$15.43M 10-K · filed 2026-03-30 | |||||||||||
| 2025-09-30 | -$3.05M 10-Q · filed 2025-11-13 | -$6.58M derived: sum of 2 quarters · filed 2026-08-06 | -$10.80M 10-Q · filed 2025-11-13 | -$13.96M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-06-30 | -$3.53M 10-Q · filed 2026-08-06 | -$7.74M 10-Q · filed 2026-08-06 | -$10.90M derived: sum of 3 quarters · filed 2026-08-06 | -$16.00M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-03-31 | -$4.21M 10-Q · filed 2026-05-13 | -$4.21M 10-Q · filed 2025-05-14 | -$7.37M derived: sum of 2 quarters · filed 2026-05-13 | -$12.47M derived: sum of 3 quarters · filed 2026-05-13 | -$16.34M derived: sum of 4 quarters · filed 2026-05-13 | ||||||||||
| 2024-12-31 | -$3.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$8.26M derived: sum of 2 quarters · filed 2026-03-30 | -$12.13M derived: sum of 3 quarters · filed 2026-03-30 | -$17.00M 10-K · filed 2026-03-30 | -$16.69M 10-K · filed 2025-03-31 | ||||||||||
| 2024-09-30 | -$5.10M 10-Q · filed 2025-11-13 | -$4.66M 10-Q · filed 2024-11-07 | -$8.97M derived: sum of 2 quarters · filed 2025-11-13 | -$13.84M 10-Q · filed 2025-11-13 | -$13.52M 10-Q · filed 2024-11-07 | -$22.87M derived: sum of 4 quarters · filed 2025-11-13 | |||||||||
| 2024-06-30 | -$3.87M 10-Q · filed 2025-08-07 | -$3.72M 10-Q · filed 2024-08-13 | -$8.74M 10-Q · filed 2025-08-07 | -$8.86M 10-Q · filed 2024-08-13 | -$17.77M derived: sum of 3 quarters · filed 2025-08-07 | -$25.31M derived: sum of 4 quarters · filed 2025-08-07 | |||||||||
| 2024-03-31 | -$4.87M 10-Q · filed 2025-05-14 | -$5.13M 10-Q · filed 2024-05-09 | -$13.89M derived: sum of 2 quarters · filed 2025-05-14 | -$21.43M derived: sum of 3 quarters · filed 2025-05-14 | -$27.98M derived: sum of 4 quarters · filed 2025-05-14 | ||||||||||
| 2023-12-31 | -$9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$16.57M derived: sum of 2 quarters · filed 2025-03-31 | -$23.11M derived: sum of 3 quarters · filed 2025-03-31 | -$31.05M 10-K · filed 2025-03-31 | -$30.31M 10-K · filed 2024-03-15 | ||||||||||
| 2023-09-30 | -$7.54M 10-Q · filed 2024-11-07 | -$14.08M derived: sum of 2 quarters · filed 2024-11-07 | -$22.02M 10-Q · filed 2024-11-07 | -$26.66M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||
| 2023-06-30 | -$6.55M 10-Q · filed 2024-08-13 | -$14.48M 10-Q · filed 2024-08-13 | -$19.12M derived: sum of 3 quarters · filed 2024-08-13 | -$28.66M derived: sum of 4 quarters · filed 2024-08-13 | |||||||||||
| 2023-03-31 | -$7.93M 10-Q · filed 2024-05-09 | -$12.57M derived: sum of 2 quarters · filed 2024-05-09 | -$22.11M derived: sum of 3 quarters · filed 2024-05-09 | -$30.94M derived: sum of 4 quarters · filed 2024-05-09 | |||||||||||
| 2022-12-31 | -$4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$14.18M derived: sum of 2 quarters · filed 2024-03-15 | -$23.01M derived: sum of 3 quarters · filed 2024-03-15 | -$31.01M 10-K · filed 2024-03-15 | |||||||||||
| 2022-09-30 | -$9.54M 10-Q · filed 2023-11-09 | -$18.37M derived: sum of 2 quarters · filed 2023-11-09 | -$26.37M 10-Q · filed 2023-11-09 | -$35.12M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||
| 2022-06-30 | -$8.83M 10-Q · filed 2023-08-01 | -$16.83M 10-Q · filed 2023-08-01 | -$25.58M derived: sum of 3 quarters · filed 2024-03-15 | -$31.18M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||
| 2022-03-31 | -$8.00M 10-Q · filed 2023-05-02 | -$16.75M derived: sum of 2 quarters · filed 2024-03-15 | -$22.35M derived: sum of 3 quarters · filed 2024-03-15 | -$27.29M derived: sum of 4 quarters · filed 2024-03-15 | |||||||||||
| 2021-12-31 | -$8.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$14.35M derived: sum of 2 quarters · filed 2024-03-15 | -$19.29M derived: sum of 3 quarters · filed 2024-03-15 | -$22.30M 10-K · filed 2024-03-15 | |||||||||||
| 2021-09-30 | -$5.60M 10-Q · filed 2022-11-03 | -$10.54M derived: sum of 2 quarters · filed 2022-11-03 | -$13.55M 10-Q · filed 2022-11-03 | -$15.44M derived: sum of 4 quarters · filed 2023-03-09 | |||||||||||
| 2021-06-30 | -$4.94M 10-Q · filed 2022-08-02 | -$7.95M 10-Q · filed 2022-08-02 | -$9.85M derived: sum of 3 quarters · filed 2023-03-09 | -$11.73M derived: sum of 4 quarters · filed 2023-03-09 | |||||||||||
| 2021-03-31 | -$3.01M 10-Q · filed 2022-05-03 | -$4.90M derived: sum of 2 quarters · filed 2023-03-09 | -$6.79M derived: sum of 3 quarters · filed 2023-03-09 | -$10.26M derived: sum of 4 quarters · filed 2023-03-09 | |||||||||||
| 2020-12-31 | -$1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$3.78M derived: sum of 2 quarters · filed 2023-03-09 | -$7.25M derived: sum of 3 quarters · filed 2023-03-09 | -$10.10M 10-K · filed 2023-03-09 | |||||||||||
| 2020-09-30 | -$1.89M 10-Q · filed 2021-11-04 | -$5.36M derived: sum of 2 quarters · filed 2021-11-04 | -$8.20M 10-Q · filed 2021-11-04 | -$12.78M derived: sum of 4 quarters · filed 2022-03-10 | |||||||||||
| 2020-06-30 | -$3.47M 10-Q · filed 2021-08-03 | -$6.32M 10-Q · filed 2021-08-03 | -$10.90M derived: sum of 3 quarters · filed 2022-03-10 | -$16.97M derived: sum of 4 quarters · filed 2022-03-10 | |||||||||||
| 2020-03-31 | -$2.84M 10-Q · filed 2021-05-04 | -$7.42M derived: sum of 2 quarters · filed 2022-03-10 | -$13.50M derived: sum of 3 quarters · filed 2022-03-10 | -$17.29M derived: sum of 4 quarters · filed 2022-03-10 | |||||||||||
| 2019-12-31 | -$4.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$10.65M derived: sum of 2 quarters · filed 2022-03-10 | -$14.45M derived: sum of 3 quarters · filed 2022-03-10 | -$19.03M 10-K · filed 2022-03-10 | |||||||||||
| 2019-09-30 | -$6.07M 10-Q · filed 2020-11-04 | -$9.87M derived: sum of 2 quarters · filed 2020-11-04 | -$14.45M 10-Q · filed 2020-11-04 | -$19.63M derived: sum of 4 quarters · filed 2021-03-09 | |||||||||||
| 2019-06-30 | -$3.80M 10-Q · filed 2020-08-04 | -$8.37M 10-Q · filed 2020-08-04 | -$13.56M derived: sum of 3 quarters · filed 2021-03-09 | -$16.47M derived: sum of 4 quarters · filed 2021-03-09 | |||||||||||
| 2019-03-31 | -$4.58M 10-Q · filed 2020-05-05 | -$9.76M derived: sum of 2 quarters · filed 2021-03-09 | -$12.67M derived: sum of 3 quarters · filed 2021-03-09 | -$17.83M derived: sum of 4 quarters · filed 2021-03-09 | |||||||||||
| 2018-12-31 | -$5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$8.09M derived: sum of 2 quarters · filed 2021-03-09 | -$13.25M derived: sum of 3 quarters · filed 2021-03-09 | -$16.56M 10-K · filed 2021-03-09 | |||||||||||
| 2018-09-30 | -$2.91M 10-Q · filed 2019-11-05 | -$8.06M derived: sum of 2 quarters · filed 2019-11-05 | -$11.38M 10-Q · filed 2019-11-05 | -$14.76M derived: sum of 4 quarters · filed 2020-03-05 | |||||||||||
| 2018-06-30 | -$5.16M 10-Q · filed 2019-08-06 | -$8.47M 10-Q · filed 2019-08-06 | -$11.86M derived: sum of 3 quarters · filed 2020-03-05 | -$14.19M derived: sum of 4 quarters · filed 2020-03-05 | |||||||||||
| 2018-03-31 | -$3.31M 10-Q · filed 2019-05-07 | -$6.70M derived: sum of 2 quarters · filed 2020-03-05 | -$9.03M derived: sum of 3 quarters · filed 2020-03-05 | -$11.38M derived: sum of 4 quarters · filed 2020-03-05 | |||||||||||
| 2017-12-31 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | -$5.72M derived: sum of 2 quarters · filed 2020-03-05 | -$8.06M derived: sum of 3 quarters · filed 2020-03-05 | -$9.72M 10-K · filed 2020-03-05 | |||||||||||
| 2017-09-30 | -$2.33M 10-Q · filed 2018-11-06 | -$4.68M derived: sum of 2 quarters · filed 2018-11-06 | -$6.34M 10-Q · filed 2018-11-06 | -$10.77M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||||
| 2017-06-30 | -$2.34M 10-Q · filed 2018-08-02 | -$1.73M 10-Q · filed 2017-08-07 | -$4.00M 10-Q · filed 2018-08-02 | -$3.24M 10-Q · filed 2017-08-07 | -$8.43M derived: sum of 3 quarters · filed 2019-03-07 | -$10.68M derived: sum of 4 quarters · filed 2019-03-07 | |||||||||
| 2017-03-31 | -$1.66M 10-Q · filed 2018-05-08 | -$1.51M 10-Q · filed 2017-05-08 | -$6.09M derived: sum of 2 quarters · filed 2019-03-07 | -$8.34M derived: sum of 3 quarters · filed 2019-03-07 | -$11.20M derived: sum of 4 quarters · filed 2019-03-07 | ||||||||||
| 2016-12-31 | -$4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$6.68M derived: sum of 2 quarters · filed 2019-03-07 | -$9.54M derived: sum of 3 quarters · filed 2019-03-07 | -$11.45M 10-K · filed 2019-03-07 | -$11.62M 10-K · filed 2017-03-03 | ||||||||||
| 2016-09-30 | -$2.25M 10-Q · filed 2017-11-09 | -$2.74M 10-Q · filed 2016-11-07 | -$5.11M derived: sum of 2 quarters · filed 2017-11-09 | -$7.02M 10-Q · filed 2017-11-09 | -$7.69M 10-Q · filed 2016-11-07 | -$10.40M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||
| 2016-06-30 | -$2.86M 10-Q · filed 2017-08-07 | -$4.94M 10-Q · filed 2017-08-07 | -$8.15M derived: sum of 3 quarters · filed 2018-03-08 | -$11.05M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||
| 2016-03-31 | -$2.08M 10-Q · filed 2017-05-08 | -$5.29M derived: sum of 2 quarters · filed 2018-03-08 | -$8.19M derived: sum of 3 quarters · filed 2018-03-08 | -$6.83M derived: sum of 4 quarters · filed 2018-03-08 | |||||||||||
| 2015-12-31 | -$3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$6.11M derived: sum of 2 quarters · filed 2018-03-08 | -$4.75M derived: sum of 3 quarters · filed 2018-03-08 | -$9.12M 10-K · filed 2018-03-08 | -$7.78M 10-K · filed 2016-03-09 | ||||||||||
| 2015-09-30 | -$2.90M 10-Q · filed 2016-11-07 | -$1.54M derived: sum of 2 quarters · filed 2016-11-07 | -$5.91M 10-Q · filed 2016-11-07 | -$10.75M derived: sum of 4 quarters · filed 2017-03-03 | |||||||||||
| 2015-06-30 | $1.36M 10-Q · filed 2016-08-09 | -$3.01M 10-Q · filed 2016-08-09 | -$7.85M derived: sum of 3 quarters · filed 2017-03-03 | -$9.23M derived: sum of 4 quarters · filed 2017-03-03 | |||||||||||
| 2015-03-31 | -$4.37M 10-Q · filed 2016-05-09 | -$9.21M derived: sum of 2 quarters · filed 2017-03-03 | -$10.59M derived: sum of 3 quarters · filed 2017-03-03 | -$12.44M derived: sum of 4 quarters · filed 2017-03-03 | |||||||||||
| 2014-12-31 | -$4.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$6.21M derived: sum of 2 quarters · filed 2017-03-03 | -$8.06M derived: sum of 3 quarters · filed 2017-03-03 | -$9.04M 10-K · filed 2017-03-03 | |||||||||||
| 2014-09-30 | -$1.38M 10-Q · filed 2015-11-13 | -$3.23M derived: sum of 2 quarters · filed 2015-11-13 | -$4.20M 10-Q · filed 2015-11-13 | -$4.95M derived: sum of 4 quarters · filed 2015-11-13 | |||||||||||
| 2014-06-30 | -$1.85M 10-Q · filed 2015-08-13 | -$2.82M 10-Q · filed 2015-08-13 | -$3.57M derived: sum of 3 quarters · filed 2015-08-13 | -$4.50M derived: sum of 4 quarters · filed 2015-08-13 | -$95.37M 10-Q · filed 2014-08-12 | ||||||||||
| 2014-03-31 | -$974.25K 10-Q · filed 2015-05-11 | -$1.72M derived: sum of 2 quarters · filed 2015-05-11 | -$2.65M derived: sum of 3 quarters · filed 2015-05-11 | -$4.06M derived: sum of 4 quarters · filed 2015-05-11 | -$93.52M 10-Q · filed 2014-05-14 | ||||||||||
| 2013-12-31 | -$749.32K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$1.67M derived: sum of 2 quarters · filed 2015-03-31 | -$3.09M derived: sum of 3 quarters · filed 2015-03-31 | -$4.72M 10-K · filed 2015-03-31 | -$92.54M 10-K · filed 2014-03-31 | ||||||||||
| 2013-09-30 | -$924.61K 10-Q · filed 2014-11-12 | -$2.34M derived: sum of 2 quarters · filed 2014-11-12 | -$3.97M 10-Q · filed 2014-11-12 | -$4.52M derived: sum of 4 quarters · filed 2014-11-12 | -$91.79M 10-Q · filed 2013-11-06 | ||||||||||
| 2013-06-30 | -$1.42M 10-Q · filed 2014-08-12 | -$3.05M 10-Q · filed 2014-08-12 | -$3.60M derived: sum of 3 quarters · filed 2014-08-12 | -$4.25M derived: sum of 4 quarters · filed 2014-08-12 | -$90.87M 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | -$1.63M 10-Q · filed 2014-05-14 | -$2.18M derived: sum of 2 quarters · filed 2014-05-14 | -$2.83M derived: sum of 3 quarters · filed 2014-05-14 | -$3.88M derived: sum of 4 quarters · filed 2014-05-14 | -$89.45M 10-Q · filed 2013-05-15 | ||||||||||
| 2012-12-31 | -$550.28K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$1.20M derived: sum of 2 quarters · filed 2014-03-31 | -$2.25M derived: sum of 3 quarters · filed 2014-03-31 | -$3.68M 10-K · filed 2014-03-31 | -$88.37M 10-K · filed 2013-04-03 | ||||||||||
| 2012-09-30 | -$651.98K 10-Q · filed 2013-11-06 | -$1.70M derived: sum of 2 quarters · filed 2013-11-06 | -$3.13M 10-Q · filed 2013-11-06 | ||||||||||||
| 2012-06-30 | -$1.05M 10-Q · filed 2013-08-14 | -$2.47M 10-Q · filed 2013-08-14 | |||||||||||||
| 2012-03-31 | -$1.43M 10-Q · filed 2013-05-15 | ||||||||||||||
| 2011-12-31 | -$5.48M 10-K · filed 2013-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |